Post COVID-19 Condition in Children and Adolescents: An Emerging Problem.

COVID-19 adolescents children long-COVID-19 long-haul COVID post COVID-19 condition post-acute COVID-19 syndrome

Journal

Frontiers in pediatrics
ISSN: 2296-2360
Titre abrégé: Front Pediatr
Pays: Switzerland
ID NLM: 101615492

Informations de publication

Date de publication:
2022
Historique:
received: 11 03 2022
accepted: 31 03 2022
entrez: 31 5 2022
pubmed: 1 6 2022
medline: 1 6 2022
Statut: epublish

Résumé

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became a pandemic in 2020 and by March 2022 had caused more than 479 million infections and 6 million deaths worldwide. Several acute and long-term symptoms have been reported in infected adults, but it remains unclear whether children/adolescents also experience persistent sequelae. Hence, we conducted a review of symptoms and pathophysiology associated with post-coronavirus disease 2019 (post-COVID-19) condition in children and adolescents. We reviewed the scientific literature for reports on persistent COVID-19 symptoms after SARS-CoV-2 infection in both children/adolescents and adults from 1 January 2020 to 31 March 2022 (based on their originality and relevance to the broad scope of this review, 26 reports were included, 8 focused on adults and 18 on children/adolescents). Persistent sequelae of COVID-19 are less common in children/adolescents than in adults, possibly owing to a lower frequency of SARS-CoV-2 infection and to the lower impact of the infection itself in this age group. However, cumulative evidence has shown prolonged COVID-19 to be a clinical entity, with few pathophysiological associations at present. The most common post-COVID-19 symptoms in children/adolescents are fatigue, lack of concentration, and muscle pain. In addition, we found evidence of pathophysiology associated with fatigue and/or headache, persistent loss of smell and cough, and neurological and/or cardiovascular symptoms. This review highlights the importance of unraveling why SARS-CoV-2 infection may cause post-COVID-19 condition and how persistent symptoms might affect the physical, social, and psychological well-being of young people in the future.

Identifiants

pubmed: 35633949
doi: 10.3389/fped.2022.894204
pmc: PMC9130634
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

894204

Informations de copyright

Copyright © 2022 Izquierdo-Pujol, Moron-Lopez, Dalmau, Gonzalez-Aumatell, Carreras-Abad, Mendez, Rodrigo and Martinez-Picado.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

EMBO J. 2020 Oct 15;39(20):e106230
pubmed: 32876341
Clin Infect Dis. 2014 Nov 15;59(10):1394-400
pubmed: 25115874
Arch Intern Med. 2009 Dec 14;169(22):2142-7
pubmed: 20008700
Lancet Respir Med. 2021 Nov;9(11):1328-1341
pubmed: 34678213
Future Microbiol. 2022 May;17:551-571
pubmed: 35264003
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Eur J Case Rep Intern Med. 2021 Apr 19;8(4):002520
pubmed: 33987131
Science. 2020 Oct 23;370(6515):
pubmed: 32972996
J R Coll Gen Pract. 1987 May;37(298):212-4
pubmed: 3320358
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33593941
Pediatr Infect Dis J. 2022 May 1;41(5):424-426
pubmed: 35213866
Cell Rep Med. 2021 May 18;2(5):100288
pubmed: 33969321
EClinicalMedicine. 2021 Aug;38:101019
pubmed: 34308300
J Infect. 2022 Feb;84(2):158-170
pubmed: 34813820
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
Nat Med. 2021 Sep;27(9):1607-1613
pubmed: 34163090
Acta Paediatr. 2021 Mar;110(3):914-921
pubmed: 33205450
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Front Microbiol. 2021 Jun 23;12:698169
pubmed: 34248921
JAMA Dermatol. 2020 Sep 1;156(9):998-1003
pubmed: 32584377
Pediatr Pulmonol. 2021 Aug;56(8):2495-2502
pubmed: 34102037
N Engl J Med. 2020 Apr 2;382(14):1370-1371
pubmed: 32163697
Infect Dis Now. 2022 Mar;52(2):75-81
pubmed: 34800742
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
J Exp Med. 2021 Mar 1;218(3):
pubmed: 33433624
World J Pediatr. 2021 Oct;17(5):495-499
pubmed: 34478045
Nature. 2021 Feb;590(7844):140-145
pubmed: 33137809
Eur J Pediatr. 2022 Mar;181(3):1105-1115
pubmed: 34738173
BMC Med. 2020 Aug 6;18(1):250
pubmed: 32762696
Cell. 2020 Jul 23;182(2):429-446.e14
pubmed: 32526206
J Transl Autoimmun. 2021;4:100100
pubmed: 33880442
Nature. 2021 Mar;591(7848):92-98
pubmed: 33307546
MMWR Morb Mortal Wkly Rep. 2020 Oct 09;69(40):1450-1456
pubmed: 33031361
Hong Kong Med J. 2009 Dec;15 Suppl 8:21-3
pubmed: 20393208
Respirology. 2010 Apr;15(3):543-50
pubmed: 20337995
Nature. 2021 Mar;591(7851):639-644
pubmed: 33461210
BMJ Open. 2021 Aug 26;11(8):e052838
pubmed: 34446502
J Clin Virol. 2007 Jan;38(1):1-6
pubmed: 17137834
Mod Pathol. 2021 Sep;34(9):1704-1709
pubmed: 34006935
Front Pediatr. 2021 Oct 29;9:752385
pubmed: 34778143
Pediatr Infect Dis J. 2021 Dec 1;40(12):e482-e487
pubmed: 34870392
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Sci Transl Med. 2020 Nov 18;12(570):
pubmed: 33139519
J Transl Med. 2018 Oct 1;16(1):268
pubmed: 30285773
Ann Intern Med. 2021 Mar;174(3):308-315
pubmed: 33226859
Am J Obstet Gynecol. 2021 Jan;224(1):35-53.e3
pubmed: 32739398
EBioMedicine. 2021 Apr;66:103339
pubmed: 33867313
Lancet Child Adolesc Health. 2021 Oct;5(10):708-718
pubmed: 34358472
Acta Paediatr. 2021 Jul;110(7):2208-2211
pubmed: 33835507
Eur J Pediatr. 2021 Jul;180(7):2019-2034
pubmed: 33599835
Arch Dis Child. 2022 Mar;107(3):e2
pubmed: 34045207
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Nat Commun. 2020 Oct 12;11(1):5128
pubmed: 33046695
Nat Rev Neurol. 2014 Aug;10(8):469-82
pubmed: 25023340
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
J Invest Dermatol. 2021 Dec;141(12):2791-2796
pubmed: 34561087
Acta Clin Belg. 2022 Aug;77(4):772-777
pubmed: 34511054
Lancet Respir Med. 2021 May;9(5):533-544
pubmed: 33857435
Sci Transl Med. 2021 Jun 2;13(596):
pubmed: 33941622
Nat Rev Dis Primers. 2016 Jan 14;2:15084
pubmed: 27188830

Auteurs

Jon Izquierdo-Pujol (J)

IrsiCaixa AIDS Research Institute, Badalona, Spain.

Sara Moron-Lopez (S)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
CIBER de Enfermedades Infecciosas, Madrid, Spain.

Judith Dalmau (J)

IrsiCaixa AIDS Research Institute, Badalona, Spain.

Alba Gonzalez-Aumatell (A)

Department of Pediatrics, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Badalona, Spain.

Clara Carreras-Abad (C)

Department of Pediatrics, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Badalona, Spain.

Maria Mendez (M)

Department of Pediatrics, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Badalona, Spain.

Carlos Rodrigo (C)

Department of Pediatrics, Germans Trias i Pujol University Hospital, Autonomous University of Barcelona, Badalona, Spain.

Javier Martinez-Picado (J)

IrsiCaixa AIDS Research Institute, Badalona, Spain.
CIBER de Enfermedades Infecciosas, Madrid, Spain.
Department of Infectious Disease and Immunity, University of Vic-Central University of Catalonia (UVic-UCC), Vic, Spain.
Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.

Classifications MeSH